Kang-Yi Su

Kang-Yi Su

Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University

Affiliated withNational Taiwan UniversityNational Taiwan University HospitalNational Taiwan University Hospital

+1

Research Area

Biography

Kang-Yi Su has not added Biography.
If you are Kang-Yi Su and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2
Year
Proofreading and DNA Repair Assay Using Single Nucleotide Extension and MALDI-TOF Mass Spectrometry Analysis
Publication title

Cited by 6

2018
2022

Other Publications

Article
Year
Dichloromethane extracts of propolis protect cell from oxygen-glucose deprivation-induced oxidative stress via reducing apoptosis.

Food & nutrition research| PubMed ID: 27329777

2016
2016
Decreased expressions of hepsin in human hepatocellular carcinomas.

Liver international : official journal of the International Association for the Study of the Liver| PubMed ID: 16911458

2006
Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 17344389

2007
2011
Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 21810691

2011
2012
2012
Potential Therapeutic Role of Z-Isochaihulactone in Lung Cancer through Induction of Apoptosis via Notch Signaling.

Evidence-based complementary and alternative medicine : eCAM| PubMed ID: 23049612

2012
2012
Potential Therapeutic Role of Hispidulin in Gastric Cancer through Induction of Apoptosis via NAG-1 Signaling.

Evidence-based complementary and alternative medicine : eCAM| PubMed ID: 24159347

2013
2014
2014
2014
2014
2014
Dynamic plasma EGFR mutation status as a predictor of EGFR-TKI efficacy in patients with EGFR-mutant lung adenocarcinoma.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer| PubMed ID: 25514801

2015
2015
2015
R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 26056182

2015
2016
2016
2016
2016
2016
2016
2016
2016
2016
2017
2017
FAM198B is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 29217529

2017
2018
Intercalated Treatment Following Rebiopsy Is Associated with a Shorter Progression-Free Survival of Osimertinib Treatment.

Cancer research and treatment : official journal of Korean Cancer Association| PubMed ID: 29228521

2017
2017
2018
2018
2018
Characteristics and Predictive Value of PD-L1 Status in Real-World Non-Small Cell Lung Cancer Patients.

Journal of immunotherapy (Hagerstown, Md. : 1997)| PubMed ID: 29683890

2018
Novel therapeutic drug identification and gene correlation for fatty liver disease using high-content screening: Proof of concept.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences| PubMed ID: 29800612

2018
2018
2018
2018
2019
2019
2019
Metabolomics Investigation of Voriconazole-Induced Hepatotoxicity in Mice.

Chemical research in toxicology| PubMed ID: 31411454

2019
2020
2020
2020
2020
2020
2021
2021
2020
2021
2022
2021
2021
2021
2022
Genetic Deletion of HLJ1 Does Not Affect Blood Coagulation in Mice.

International journal of molecular sciences| PubMed ID: 35216179

2022